{"product_id":"global-pharmacy-benefit-management-pbm-market-growth-status-and-outlook-2023-2029","title":"Global Pharmacy Benefit Management (PBM) Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Pharmacy Benefit Management (PBM) Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eThe term pharmacy benefit management (PBM) industry refers to a group of companies that serve as the middlemen between insurance companies, pharmacies, and drug manufacturers. PBMs are responsible for securing lower drug costs for insurers and insurance companies. They accomplish this by negotiating with pharmacies and drug manufacturers. The discounts are then passed onto insurance companies. Profits are generated through the slight up-charging of drugs or retaining portions of rebates.\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Pharmacy Benefit Management (PBM) Industry Forecast” looks at past sales and reviews total world Pharmacy Benefit Management (PBM) sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmacy Benefit Management (PBM) sales for 2023 through 2029. With Pharmacy Benefit Management (PBM) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmacy Benefit Management (PBM) industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Pharmacy Benefit Management (PBM) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmacy Benefit Management (PBM) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmacy Benefit Management (PBM) market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmacy Benefit Management (PBM) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmacy Benefit Management (PBM).\u003c\/p\u003e\n\n\u003cp\u003eThe global Pharmacy Benefit Management (PBM) market size is projected to grow from US$ 460290 million in 2022 to US$ 688130 million in 2029; it is expected to grow at a CAGR of 5.9% from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eThree major PBMs maufacturters include Express Scripts, CVS Health, and OptumRx, which comprise 75% of the market.\u003c\/p\u003e\n\n\u003cp\u003eAmerica is enjoying the largest market share of pharmacy benefit management (PBM), with a market share nearly 97%. EU is the second place, enjoying market share nearly 2%.In terms of product, government is the largest segment, with a share over 70%. And in terms of application, the largest application is non-mail pharmacy services, followed by mail-order pharmacy services.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Pharmacy Benefit Management (PBM) market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nGovernment\u003cbr\u003e\nNon-Government\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nMail-order Pharmacy Services\u003cbr\u003e\nNon-mail Pharmacy Services\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\n United States\u003cbr\u003e\n Canada\u003cbr\u003e\n Mexico\u003cbr\u003e\n Brazil\u003cbr\u003e\nAPAC\u003cbr\u003e\n China\u003cbr\u003e\n Japan\u003cbr\u003e\n Korea\u003cbr\u003e\n Southeast Asia\u003cbr\u003e\n India\u003cbr\u003e\n Australia\u003cbr\u003e\nEurope\u003cbr\u003e\n Germany\u003cbr\u003e\n France\u003cbr\u003e\n UK\u003cbr\u003e\n Italy\u003cbr\u003e\n Russia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\n Egypt\u003cbr\u003e\n South Africa\u003cbr\u003e\n Israel\u003cbr\u003e\n Turkey\u003cbr\u003e\n GCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\nCVS Health (CVS)\u003cbr\u003e\nExpress Scripts\u003cbr\u003e\nOptumRx (UnitedHealth)\u003cbr\u003e\nHumana Pharmacy Solutions\u003cbr\u003e\nPrime Therapeutics\u003cbr\u003e\nMedimpact Healthcare\u003cbr\u003e\nMagellan Health\u003cbr\u003e\nBC\/BS\u003cbr\u003e\nVidalink\u003cbr\u003e\nSea Rainbow\u003cbr\u003e\nCachet\u003cbr\u003e\nCRHMS\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 100 Pages \/ MCW16239595","offer_id":47656710897970,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-pharmacy-benefit-management-pbm-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}